2024
|
G/S
|
pharmaceutical preparations containing hyaluronic acid for the treatment of facial wrinkles, asym... |
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of migraines, headaches and pain. |
|
G/S
|
Pharmaceutical preparations for the treatment of wrinkles. |
|
G/S
|
Pharmaceutical preparations for the treatment of wrinkles |
|
G/S
|
Pharmaceutical preparations containing botulinum toxin for the treatment of facial wrinkles, asym... |
|
G/S
|
pharmaceutical preparations containing botulinum toxin for the treatment of facial wrinkles, asym... |
|
Invention
|
Injection device.
A needle assembly for an injection device is provided to facilitate delivery o... |
|
G/S
|
Pharmaceutical preparations for the treatment of wrinkles |
|
G/S
|
ophthalmic preparations; eye drops; lubricating and rewetting solutions for eyes |
|
Invention
|
Devices for injection and dosing.
Skin can be treated by piercing skin with a plurality of needl... |
|
Invention
|
Time released biodegradable or bioerodible microspheres or microparticles suspended in a solidify... |
|
Invention
|
Presbyopia treatments.
Described herein are methods and compositions for the treatment of ocular... |
|
Invention
|
Ocular implant made by a double extrusion process.
The invention provides biodegradable implants... |
|
G/S
|
pharmaceutical preparations to treat dermatological conditions; medical preparations consisting o... |
|
G/S
|
Health care consulting in the field of migraines, cluster headaches and tension headaches; Health... |
|
Invention
|
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof.
Described herein are compounds, or p... |
|
Invention
|
Use of alpha-2-adrenergic receptor agonists for improving vision.
Methods of using the alpha-2-a... |
|
Invention
|
Implantable prostheses for tissue expansion.
A method of manufacturing a tissue expander for imp... |
|
Invention
|
Dermal filler compositions.
The present invention provides highly injectable, long-lasting hyalu... |
|
Invention
|
Pharmaceutical compositions of alpha-2-adrenergic receptor agonists and their use for improving v... |
|
Invention
|
Non-protein clostridial toxin compositions.
Pharmaceutical compositions that stabilize a Clostri... |
|
Invention
|
Alpha-2-adrenergic receptor agonists for reducing redness and increasing whiteness in eyes and ot... |
|
Invention
|
Processes for making cyclic lipid implants for intraocular use.
Biocompatible implants comprisin... |
|
G/S
|
ophthalmological preparations; eye drops; lubricating and rewetting solutions for eyes |
|
Invention
|
Complement component c5 antibodies.
The present disclosure relates to antibodies and polynucleot... |
|
Invention
|
Stabilized omega-3 ophthalmic compositions.
Stabilized ophthalmic compositions containing omega-... |
|
Invention
|
Efficient lipid delivery to human tear film using a salt-sensitive emulsion system.
Provided her... |
|
Invention
|
Eye drop formulation with enhanced properties by combining sodium hyaluronate with carboxymethylc... |
|
Invention
|
Prostamide-containing intraocular implant.
Prostamide-containing biodegradable intraocular impla... |
2023
|
Invention
|
Coacervate hyaluronan hydrogels for dermal filler applications.
The present disclosure provides ... |
|
Invention
|
Immuno-based retargeted endopeptidase activity assays.
The present specification discloses a ret... |
|
Invention
|
Aspiration and injection device.
An aspiration and injection device is provided that can allow f... |
|
Invention
|
Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue au... |
|
Invention
|
Cross linked silk-hyaluronic acid composition.
Compositions useful as dermal fillers and methods... |
|
Invention
|
Intraocular pressure reduction with intracameral bimatoprost implants.
The present invention pro... |
|
Invention
|
Hyaluronic acid-collagen matrices for dermal filling and volumizing applications.
Hydrogels comp... |
|
Invention
|
Dual plane breast implant.
A soft breast prosthesis is provided, the prosthesis having a surface... |
|
Invention
|
Self-emulsifying drug delivery (sedds) for ophthalmic drug delivery.
Provided herein are topical... |
|
Invention
|
Bioerodible matrix for tissue involvement.
Disclosed herein are polyurethane polymer matrices wi... |
|
Invention
|
Prevention of post-operative atrial fibrillation with a botulinum toxin. Methods are provided for... |
|
Invention
|
Intracameral implant for treatment of an ocular condition.
The disclosure teaches precisely engi... |
|
G/S
|
operation of telephone call centers for healthcare professionals in the field of eye care product... |
|
Invention
|
Ketorolac tromethamine compositions for treating or preventing ocular pain.
The present inventio... |
|
Invention
|
Polymeric implants.
Biocompatible microparticles include an ophthalmically active cyclic lipid c... |
|
Invention
|
Injection paradigm for administration of botulinum toxins.
Disorders such as headaches can be tr... |
|
Invention
|
Amide derivatives of n-urea substituted amino acids as formyl peptidereceptor like-1 (fprl-1) rec... |
|
Invention
|
Compositions for the treatment of dry eye.
The present invention relates to ophthalmic compositi... |
|
G/S
|
Ophthalmic preparations; Eye drops; Lubricating and rewetting solutions for eyes, namely, lubrica... |
|
G/S
|
Providing information to patients via a website relating to cosmetic skin care treatments using b... |
|
Invention
|
Intracameral sustained release therapeutic agent implants.
Described herein are intracameral imp... |
|
Invention
|
Method to manufacture a stable protein.
A Clostridial toxin pharmaceutical composition comprisin... |
|
Invention
|
Prostamide-containing intraocular implants and methods of use thereof.
Prostamide-containing int... |
|
Invention
|
Artificial tears and therapeutic uses.
The present invention provides ophthalmic compositions, e... |
|
Invention
|
Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity.
Disclos... |
|
Invention
|
Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith.
M... |
|
Invention
|
Animal protein-free pharmaceutical compositions.
Animal protein-free, solid-form Clostridial tox... |
|
G/S
|
Ophthalmic preparations. |
|
Invention
|
Sustained-release implants for lowering intraocular pressure with extended duration of effect.
M... |
|
Invention
|
Syringe extrusion accessory.
A method of treatment may include providing a syringe having medici... |
2022
|
G/S
|
Ophthalmological preparations |
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, overac... |
|
G/S
|
Enhancing healthcare professionals' understanding of botulinum toxin, namely, providing education... |
|
G/S
|
Charitable services, namely, providing care packages consisting primarily of personal items for i... |
|
G/S
|
Educational services, namely, providing training services in the nature of training sessions, cla... |
|
Invention
|
Combination therapy using clostridial toxin derivative and at least one chemical depolarizing age... |
|
G/S
|
Printed medical educational brochures for healthcare providers and their patients regarding custo... |
2020
|
Invention
|
Bottle holder |